CN104151246A - 一种4-氨基安替比林缩2-萘甲醛席夫碱及应用 - Google Patents

一种4-氨基安替比林缩2-萘甲醛席夫碱及应用 Download PDF

Info

Publication number
CN104151246A
CN104151246A CN201410417906.3A CN201410417906A CN104151246A CN 104151246 A CN104151246 A CN 104151246A CN 201410417906 A CN201410417906 A CN 201410417906A CN 104151246 A CN104151246 A CN 104151246A
Authority
CN
China
Prior art keywords
naphthaldehyde
schiff
contracting
base
aminoantipyrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410417906.3A
Other languages
English (en)
Other versions
CN104151246B (zh
Inventor
刘峥
李巍
魏席
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guilin University of Technology
Original Assignee
Guilin University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilin University of Technology filed Critical Guilin University of Technology
Priority to CN201410417906.3A priority Critical patent/CN104151246B/zh
Publication of CN104151246A publication Critical patent/CN104151246A/zh
Application granted granted Critical
Publication of CN104151246B publication Critical patent/CN104151246B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/46—Oxygen atom in position 3 or 5 and nitrogen atom in position 4
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1018—Heterocyclic compounds
    • C09K2211/1025—Heterocyclic compounds characterised by ligands
    • C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

本发明公开了一种4-氨基安替比林缩2-萘甲醛席夫碱及应用。4-氨基安替比林缩2-萘甲醛席夫碱分子式为C22H19N3O，分子量为341.40，熔点为214℃-216℃。（1）称取0.78g2-萘甲醛，溶于10mL无水甲醇中，完全溶解后转移至三口烧瓶中，在35℃水浴条件下磁力搅拌；（2）称取1.0162g4-氨基安替比林溶于10mL无水甲醇中，超声溶解；（3）将步骤（2）所得溶液缓慢滴加到步骤（1）所得溶液中；在60℃磁力搅拌条件下回流4小时，冷却、过滤、滤液在室温下静置两周后有黄色晶体生成，过滤，晾干后得到4-氨基安替比林缩2-萘甲醛席夫碱即C22H19N3O。4-氨基安替比林缩2-萘甲醛能作为荧光探针在荧光分析领域得到应用。

Description

一种4-氨基安替比林缩2-萘甲醛席夫碱及应用
技术领域
本发明涉及4-氨基安替比林缩2-萘甲醛席夫碱的合成，所述的席夫碱晶体具有层状结构，其较强的荧光性质使其可作为荧光探针在分析领域得到应用。
背景技术
席夫碱是指含有活泼羰基和氨基的两类物质通过缩合反应形成的含C＝N基的一类有机化合物。在国内，关于席夫碱的合成工作起步较晚，但发展较快。近年来，已有大量文献对有关席夫碱及其配合物进行报道。随着席夫碱及其金属配合物研究的不断深入，人们发现其具有良好的荧光特性,可以用作荧光分子探针和荧光分子开关，应用于分析化学和生物化学领域。一般情况下，“刚性、平面、大共轭∏键”是荧光化合物的结构特征，有针对性的合成具有荧光特征结构的席夫碱化合物是一项很有意义的研究工作。4-氨基安替比林席夫碱具有以下几个明显的特点：(1)4-氨基安替比林分子结构中的芳香环可增大分子共轭体系且席夫碱的C＝N又有流动性的电子桥，能增强荧光发射，另外大的共轭体系在使低维分子形成更高维的超分子网络结构起到重要的作用，所以4-氨基安替比林席夫碱可以成为性能优良的荧光试剂；(2)从弱相互作用和分子几何学的角度来看，芳香环的存在也为网络内和网络间的π…π堆积的形成提供了更便利的条件，这也有利于超分子网络结构的形成，从而影响荧光的性质，因此4-氨基安替比林席夫碱合成，为此类化合物在荧光分析领域中的应用开发提供了可能。4-氨基安替比林缩2-萘甲醛是一种新的4-氨基安替比林席夫碱，其晶体结构未见报道，本专利提出了一种具有层状结构的4-氨基安替比林缩2-萘甲醛席夫碱的合成方法，为进一步研究4-氨基安替比林缩2-萘甲醛席夫碱结构及其与荧光性质的关系提供基础数据。
发明内容
本发明的目的就是要合成具有层状结构的4-氨基安替比林缩2-萘甲醛席夫碱席夫碱，使其具有较强的荧光性质，而能作为荧光探针在分析领域得到应用。
本发明涉及的4-氨基安替比林缩2-萘甲醛席夫碱分子式为C22H19N3O，分子量为341.40，熔点为214℃-216℃，其晶体学数据见表1，键长和键角见表2。
表1：4-氨基安替比林缩2-萘甲醛席夫碱的晶体学数据
complexes
Empirical formula C22H19N3O
Formula weight 341.40
Temperature/K 298
Wavelength/A° 0.71
Crystal system Monoclinic
Space group P21/n
注：w＝1/[σ2(Fo2)+0.064P)2+2.185P],P＝(Fo2+2Fc2)/3
表2：4-氨基安替比林缩2-萘甲醛席夫碱键长和键角(°)
4-氨基安替比林缩2-萘甲醛席夫碱的合成方法具体步骤为：
(1)称取5mmol(0.78g)2-萘甲醛，溶于10mL无水甲醇中，完全溶解后转移至三口烧瓶中，在35℃水浴条件下磁力搅拌。
(2)称取5mmol(1.0162g)4-氨基安替比林溶于10mL无水甲醇中，超声溶解。
(3)将步骤(2)所得溶液缓慢滴加到步骤(1)所得溶液中；在60℃磁力搅拌条件下回流4小时，冷却、过滤、滤液在室温下静置两周后有黄色晶体生成，过滤，晾干后得到4-氨基安替比林缩2-萘甲醛席夫碱(C22H19N3O)。
4-氨基安替比林缩2-萘甲醛能作为荧光探针在荧光分析领域得到应用。
附图说明
图1为本发明实施例制得的4-氨基安替比林缩2-萘甲醛席夫碱晶体结构图。
图2为本发明实施例制得的4-氨基安替比林2-萘甲醛席夫碱晶体三维堆积图。
图3为本发明实施例制得的4-氨基安替比林缩2-萘甲醛席夫碱DMF溶液荧光光谱图。
具体实施方式
实施例：
4-氨基安替比林缩2-萘甲醛席夫碱的合成：
(1)称取5mmol(0.78g)2-萘甲醛，溶于10mL无水甲醇中，完全溶解后转移至三口烧瓶中，在35℃水浴条件下磁力搅拌。
(2)称取5mmol(1.0162g)4-氨基安替比林溶于10mL无水甲醇中，超声溶解。
(3)将步骤(2)所得溶液缓慢滴加到步骤(1)所得溶液中；在60℃磁力搅拌条件下回流4小时，冷却、过滤、滤液在室温下静置两周后有黄色晶体生成，过滤，晾干后得到4-氨基安替比林缩2-萘甲醛席夫碱(C22H19N3O)。
制得的4-氨基安替比林缩2-萘甲醛席夫碱晶体结构分析：选取尺寸为0.35×0.33×0.32mm的4-氨基安替比林缩2-萘甲醛席夫碱黄色单晶安装在玻璃纤维上，在Bruker Smart CCD型X-射线衍射分析仪面探衍射仪进行晶体结构测定，在293(2)K下，采用石墨化的Mo Kα射线以ω扫描方式在3.5≤θ≤27.9°范围内共收集8046个衍射点，其中4529个独立衍射点，2644个I>2σ(I)的可观测衍射点用于结构分析和结构修正。全部数据经Lp因子和经验吸收校正，晶体结构由直接法解出，对全部非氢原子及其各向异性热参数进行全矩阵最小二乘法修正，氢原子由理论值给出。所有计算使用SHELXS97、SHELXL97程序完成。
从4-氨基安替比林缩2-萘甲醛席夫碱的结晶学参数和结构精修参数(表1)可知，4-氨基安替比林缩2-萘甲醛席夫碱属于单斜晶系，空间群为P21/c，晶胞参数为a＝7.0655(4)，b＝26.1707(18)，c＝9.1052(6)，α＝90.00，β＝97.687(6)，γ＝90.00，V＝1668.52(18)。由附图中图1和图2看出，4-氨基安替比林缩2-萘甲醛席夫碱晶体分子结构是线性的非对称分子，在该结构中，2-萘甲醛和相邻的碳原子形成π-π共轭呈平面结构，而亚氨基和吡唑啉酮共面性。从三维堆积图可以看出，席夫碱分子结构中以2-萘甲醛的双苯环交替并行为轴，4-氨基安替比林上的苯环相互平行，交叉排列形成一个M型图案，层与层之间可能是静电引力，范德华力，分子间的弱作用力的共同作用下，交叉排列，堆垛成三维结构。
4-氨基安替比林缩2-萘甲醛席夫碱红外光谱分析：在1616.07cm-1位置出现了C＝N的伸缩振动吸收峰，苯环的骨架振动吸收峰位于1593.06cm-1、1575.21cm-1及1494.88cm-1处，证明有苯基存在，CH3的弯曲振动峰出现在1456.20cm-1和1372.89cm-1处，1693.06cm-1处的吸收峰可归属为酮C＝O的伸缩振动峰。从紫外光谱图中可知4-氨基安替比林缩2-萘甲醛席夫碱出现两个明显的吸收峰，在265nm处吸收峰，根据分子结构判断，可将其归属为共轭的C＝N发生的π～π*跃迁，而在350nm处的尖锐吸收峰为吡唑环的C＝O的n～π*跃迁。
4-氨基安替比林缩2-萘甲醛作为荧光探针在荧光分析领域得到应用。

Claims (2)

1.一种4-氨基安替比林缩2-萘甲醛席夫碱，其特征在于所述4-氨基安替比林缩2-萘甲醛席夫碱分子式为C22H19N3O，分子量为341.40，熔点为214℃-216℃，其晶体学数据见表1，键长和键角见表2；
表1：4-氨基安替比林缩2-萘甲醛席夫碱的晶体学数据
注：w＝1/[σ2(Fo2)+0.064P)2+2.185P],P＝(Fo2+2Fc2)/3
表2：4-氨基安替比林缩2-萘甲醛席夫碱键长和键角(°)
所述4-氨基安替比林缩2-萘甲醛席夫碱的合成方法为：
(1)称取0.78g 2-萘甲醛，溶于10mL无水甲醇中，完全溶解后转移至三口烧瓶中，在35℃水浴条件下磁力搅拌；
(2)称取1.0162g 4-氨基安替比林溶于10mL无水甲醇中，超声溶解；
(3)将步骤(2)所得溶液缓慢滴加到步骤(1)所得溶液中；在60℃磁力搅拌条件下回流4小时，冷却、过滤、滤液在室温下静置两周后有黄色晶体生成，过滤，晾干后得到4-氨基安替比林缩2-萘甲醛席夫碱即C22H19N3O。
2.根据权利要求1所述的4-氨基安替比林缩2-萘甲醛席夫碱的应用，其特征在于4-氨基安替比林缩2-萘甲醛能作为荧光探针在荧光分析领域得到应用。
CN201410417906.3A 2014-08-23 2014-08-23 一种4-氨基安替比林缩2-萘甲醛席夫碱及应用 Active CN104151246B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410417906.3A CN104151246B (zh) 2014-08-23 2014-08-23 一种4-氨基安替比林缩2-萘甲醛席夫碱及应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410417906.3A CN104151246B (zh) 2014-08-23 2014-08-23 一种4-氨基安替比林缩2-萘甲醛席夫碱及应用

Publications (2)

Publication Number Publication Date
CN104151246A true CN104151246A (zh) 2014-11-19
CN104151246B CN104151246B (zh) 2016-06-29

Family

ID=51876907

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410417906.3A Active CN104151246B (zh) 2014-08-23 2014-08-23 一种4-氨基安替比林缩2-萘甲醛席夫碱及应用

Country Status (1)

Country Link
CN (1) CN104151246B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108147997B (zh) * 2018-02-27 2020-07-10 淮阴师范学院 吡唑醛缩苯胺席夫碱化合物及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101186594A (zh) * 2007-12-13 2008-05-28 江苏省原子医学研究所 (z)-2,4-二甲氧基-6-苯乙烯基-5-(席夫碱或苯甲酰腙)基苯类化合物及其制备方法
WO2012041524A1 (en) * 2010-10-01 2012-04-05 Max-Delbrück-Centrum Für Molekulare Medizin (Mdc) Hydrazonopyrazolones as protein tyrosine phosphatase inhibitors
WO2013072921A2 (en) * 2011-09-13 2013-05-23 Glenmark Generics Limited Process for preparation of substituted 3'-hydrazino-biphenyl-3-carboxylic acid compounds
CN103980252A (zh) * 2014-05-30 2014-08-13 遵义医学院 制备含1,2,4-三氮唑的吡唑类席夫碱治疗肿瘤的药物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101186594A (zh) * 2007-12-13 2008-05-28 江苏省原子医学研究所 (z)-2,4-二甲氧基-6-苯乙烯基-5-(席夫碱或苯甲酰腙)基苯类化合物及其制备方法
WO2012041524A1 (en) * 2010-10-01 2012-04-05 Max-Delbrück-Centrum Für Molekulare Medizin (Mdc) Hydrazonopyrazolones as protein tyrosine phosphatase inhibitors
WO2013072921A2 (en) * 2011-09-13 2013-05-23 Glenmark Generics Limited Process for preparation of substituted 3'-hydrazino-biphenyl-3-carboxylic acid compounds
CN103980252A (zh) * 2014-05-30 2014-08-13 遵义医学院 制备含1,2,4-三氮唑的吡唑类席夫碱治疗肿瘤的药物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MOUSTAFA, M. A.，等: "Synthesis of certain antipyryl derivatives as potential analgesics", 《SCIENTIA PHARMACEUTICA》 *

Also Published As

Publication number Publication date
CN104151246B (zh) 2016-06-29

Similar Documents

Publication Publication Date Title
Huang et al. Synthesis, characterization and antitumor activity of novel ferrocene derivatives containing pyrazolyl-moiety
Rao et al. 2-hydroxy-1-naphthaldehyde-derived Schiff bases: synthesis, characterization, and structure
Costes et al. Pentacoordinate NiII complexes: preparation, magnetic measurements, and ab initio calculations of the magnetic anisotropy terms
Raza et al. Synthesis of two new Schiff bases; crystal structure, Hirshfeld surface analysis, density functional theory and molecular docking
CN104447804A (zh) 间苯双三唑Cu-三氟甲磺酸配合物及其制备方法与应用
Mullice et al. Rhenium complexes of chromophore-appended dipicolylamine ligands: syntheses, spectroscopic properties, DNA binding and X-ray crystal structure
Tao et al. Spontaneous resolution and structure transformation of niII metal–organic frameworks from an achiral precursor
Niu et al. Ferrocene-based imidazolium receptors for anions
Zhou et al. Asymmetric Copper (II)‐Catalysed Nitroaldol (Henry) Reactions Utilizing a Chiral C1‐Symmetric Dinitrogen Ligand
CN104151246A (zh) 一种4-氨基安替比林缩2-萘甲醛席夫碱及应用
Jin et al. Sonochemical effect on two new Ruthenium (II) complexes with ligand (E)-N-((6-bromopyridin-2-yl) methylene)-4-(methylthio) aniline precursors for synthesis of RuO2 nanoparticles
CN102030702B (zh) 一种空穴传输材料及其合成方法
CN107353312A (zh) 一种含dppf骨架和O‑烷基二硫代磷酸配体的[镍铁]氢化酶模型物及其制备方法
Panda et al. Switching of aromatic free base triphyrin (2.1. 1) to antiaromatic phosphorus (v) complexes of triphyrin (2.1. 1)
CN104193684A (zh) 4-氨基安替比林缩2,5-二羟基苯甲醛席夫碱及应用
Chandrasekhar et al. syntheses of chromium and copper complexes of hexaazamacrocycles. Crystal structures of chromium (III) complexes of 1, 4, 7, 10, 13, 16-hexaazacyclooctadecane and 1, 4, 7, 11, 14, 17-hexaazacycloeicosane
CN104151247A (zh) 一种4-氨基安替比林缩异香草醛席夫碱的合成及应用
Basavaiah et al. (5S)-1, 3-Diaza-2-imino-3-phenylbicyclo [3.3. 0] octane: first example of guanidine based in situ recyclable chiral catalytic source for borane-mediated asymmetric reduction of prochiral ketones
CN104151288A (zh) 一种噻吩-2-甲醛缩邻氨基苯硫酚席夫碱的合成及应用
Wen et al. A 3D porous zinc MOF constructed from a flexible tripodal ligand: synthesis, structure, and photoluminescence property
CN104341458A (zh) 一种Co(II)-氮氧自由基配合物及其制备方法
Ha et al. An economic, practical access to enantiopure 1, 1′-bi-2-naphthols: enantioselective complexation of threo-(1S, 2S)-N-benzyl-N, N-dimethyl [1, 3-dihydroxy-1-(4′-nitrophenyl)]-2-propylammonium chloride
Shen et al. A macrocyclic ligand 5, 14-dihydro-6, 15-dimethyl-8, 17-diphenyldibenzo-[b, i][1, 4, 8, 11] tetraazacyclotetradecine and its nickel (II) complex: Syntheses, reaction mechanism and structures
Zheng et al. Cooperative N–H··· N, N–H··· O, and O–H··· N bonded molecular dimers of two new 3, 5-diaryl-1 H-pyrazoles
CN104086602A (zh) 一种带有三足配体的羰基钴配合物及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant